These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 30963302)

  • 1. Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.
    Yang F; Ma L; Zhang L; Wang Y; Zhao C; Zhu W; Liang W; Liu Q
    Heart Vessels; 2019 Oct; 34(10):1608-1614. PubMed ID: 30963302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the serum lipoprotein-associated phospholipase A
    Dong L; Tong J; Fan S
    Cardiovasc J Afr; 2023 Nov-Dec 23; 34(5):273-277. PubMed ID: 36637451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change of Inflammatory Factors in Patients with Acute Coronary Syndrome.
    Ma CY; Xu ZY; Wang SP; Peng HY; Liu F; Liu JH; Ren FX
    Chin Med J (Engl); 2018 Jun; 131(12):1444-1449. PubMed ID: 29893361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-Associated Phospholipase A2 in Cardiac Disease: a Potential Early Biomarker of Unstable Coronary Artery Disease.
    Li J; Zhou Z; Niu X; Li H
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II).
    Möckel M; Müller R; Vollert J; Müller C; Danne O; Gareis R; Störk T; Dietz R; Koenig W
    Clin Res Cardiol; 2007 Sep; 96(9):604-12. PubMed ID: 17593313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosis.
    Verdoia M; Rolla R; Gioscia R; Rognoni A; De Luca G;
    J Thromb Thrombolysis; 2023 Jul; 56(1):37-44. PubMed ID: 37022507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemia-modified albumin: is it a promising marker in acute coronary syndrome?
    Ralapanawa U; Sivakanesan R; Tennakoon S; Karunathilake P
    BMC Cardiovasc Disord; 2024 Aug; 24(1):436. PubMed ID: 39174920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Lipoprotein-Associated Phospholipase A2 Level Is an Independent Predictor of High Thrombus Burden in Patients With Acute ST-segment Elevation Myocardial Infarction.
    Wu X; Zhang Y; Wu Z; You W; Liang F; Ye F; Chen S
    Int Heart J; 2016 Dec; 57(6):689-696. PubMed ID: 27818473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Miljković A; Ignjatovic S; Mrdovic I; Matic D; Savic L; Ostojic M; Vasiljevic Z
    Clin Lab; 2012; 58(11-12):1135-44. PubMed ID: 23289182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Lp-PLA2 in acute coronary syndrome: association with major adverse cardiac events in a community-based cohort.
    Li N; Li S; Yu C; Gu S
    Postgrad Med; 2010 Jul; 122(4):200-5. PubMed ID: 20675983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pentraxin-3 and ischemia-modified albumin with troponin in early diagnosis of acute coronary syndrome.
    Demir MT; Baydin A; Amanvermez R; Erenler AK; Güzel M; Yücel O
    Bratisl Lek Listy; 2018; 119(8):509-512. PubMed ID: 30160160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndrome.
    Li J; Wang H; Tian J; Chen B; Du F
    Medicine (Baltimore); 2018 Jul; 97(28):e11517. PubMed ID: 29995820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship Between the Level of Serum ESM-1 and Lp-PLA2 in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    Wei P; Zong B; Liu X; Zhang M; Yang C; Wang H; Fu Q; Wang L; Cao B
    Clin Transl Sci; 2021 Jan; 14(1):179-183. PubMed ID: 32710501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris.
    Wudkowska A; Goch J; Goch A
    Kardiol Pol; 2010 Apr; 68(4):431-7. PubMed ID: 20425705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of serum lipoprotein-associated phospholipase A2, ischemia-modified albumin, and cystatin C in predicting coronary heart disease risk: a single center retrospective cohort study.
    Le QF; Liu J; Chen L
    Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10730-10735. PubMed ID: 37975398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is lipoprotein-associated phospholipase A2 activity correlated with fibrous-cap thickness and plaque volume in patients with acute coronary syndrome?
    Gu X; Hou J; Yang S; Yu H; Tian J; Liu F; Li N; Yu B; Jang IK
    Coron Artery Dis; 2014 Jan; 25(1):10-5. PubMed ID: 24089018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipoprotein-associated phospholipase A2 mass is elevated in STEMI compared to non-STEMI patients but does not discriminate between myocardial infarction and non-cardiac chest pain.
    Dullaart RP; van Pelt LJ; Kwakernaak AJ; Dikkeschei BD; van der Horst IC; Tio RA
    Clin Chim Acta; 2013 Sep; 424():136-40. PubMed ID: 23756128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
    Cai A; Li G; Chen J; Li X; Li L; Zhou Y
    BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease.
    Zhang H; Gao Y; Wu D; Zhang D
    BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.